When the body encounters infection or cancer, cytotoxic T lymphocytes attach to the affected cell and form the immune synapse ...

When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...

Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a ...

A CAR-T therapy used to treat cancer managed to reset the immune system and bring three autoimmune diseases into remission in ...

Mission Bio, the single-cell multi-omics leader, today released data showing that its Targeted Single-Cell DNA+RNA Assay ...

CapyBio, a cell identity tools and services company, today announced the launch of three new commercial analysis services: Capybara™ Benchmarking Analysis, Capybara Advanced Analysis, and CellOracle™ ...

Researchers from Utah State University, University of Utah Health, the Helmholtz Institute for RNA-based Infection Research ...

A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while leaving healthy cells untouched. The technology has largely been tested in cells ...

A collaboration between the University of Geneva and Lausanne University Hospital has shown in new detail how the body's defenses fight back against malignant cells. Those defenses involve T ...

Different types of cell division failure shape whether duplicated cells survive, remain stable, or lead to cancer.

A single-cell platform reveals that many genetic mutations converge on shared cellular programs, pointing to simpler, more ...

T cells, which target infection and disease, can become more effective after a meal. The finding might help improve ...